Disclosure of Relevant Financial Relationships with Commercial Interests

USF Health endorses the standards of the ACCME and all applicable accrediting organizations that require everyone in a position to control the content of a CME activity to disclose all financial relationships with commercial interests that are related to the content of the CME activity. CME activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which, therefore, may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. USF Health does not endorse any products or services.

Relevant financial relationships exist between the following individuals and commercial interests:

Author

Alessandra Mangia, MD

Liver Unit Hospital 'Casa Sollievo della Sofferenza'
Istituto di Ricovero e Cura a Carattere Scientifico
San Giovanni Rotondo, Italy

Alessandra Mangia, MD, has disclosed that she has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, and Merck Sharp & Dohme and funds for research support from Gilead Sciences, Janssen, and Merck Sharp & Dohme.

Editor In Chief

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees or fees for non-CME/CE services from AbbVie, Gilead Sciences, and Merck. Dr. Zeuzem has disclosed in previous editions that he had served as a consultant or on advisory boards for Abbott, AbbVie, Achillion, Anadys, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Idenix, iTherX, Janssen, Merck, Novartis, Pfizer, Pharmasset, Presidio, Roche, Santaris, Tibotec/Janssen, and Vertex and had served on speaker bureaus for AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and Roche.

Staff

Edward King, MA

Executive Vice President

Edward King, MA, has no real or apparent conflicts of interest to report.

Jennifer M. Blanchette, PhD

Managing Editor

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Clinical Editor

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

USF Health OCPD staff members and the peer/content reviewers for this activity have no relevant financial relationships to disclose. Disclosures are on file at the USF Health Office of Continuing Professional Development.

Additional Disclosure Information

The following faculty or staff have previously contributed to the content of this module and disclosed the following potential conflicts of interest:

Tram T. Tran, MD, disclosed that she had received consulting fees, fees for non-CME/CE services, and funds for research support from Bristol-Myers Squibb and Gilead Sciences and that she had served as a consultant for Vertex at the time she contributed to this module.

Nezam H. Afdhal, MD, FRCPI, disclosed that he had served as a consultant or on advisory boards for AbbVie, Achillion, Boehringer Ingelheim, Biogen, Biolex, Echosens, FibroGen, Gilead Sciences, GlaxoSmithKline, Idera, Janssen, Kadmon, Ligand, Medgenics, Merck, Novartis, Spring Bank, and Vertex; had received funds for research support from Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Quest, and Vertex; and had held stock options for Medgenics and Spring Bank at the time he contributed to this module.

Anna S. F. Lok, MD, disclosed that she had received consulting fees from Gilead Sciences and GlaxoSmithKline and funds for research support from Bristol-Myers Squibb and Gilead Sciences at the time she contributed to this module.

Rachael M. Andrie, PhD; Sheralee Connors, MA; Heather Stieglitz, PhD; Taryn O’Loughlin Gross, PhD; Michaela R. Ryan, PhD; Anna Poppa; Michael Westhafer, MD; and Rachel Whitmire had no real or apparent conflicts of interest to report at the time they contributed to this module.

Norah Terrault, MD, MPH, disclosed that she had served as a consultant for Biotest, Bristol-Myers Squibb, Gilead Sciences, Merck, Pfizer, Roche/Genentech, and Siemens and had received funds for research support from Bristol-Myers Squibb, Eisai, Gilead Sciences, Merck, Novartis, and Roche/Genentech at the time she contributed to this module.

Disclaimer

The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Unapproved Use Disclosure

USF Health requires CME faculty to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may/will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

USF Health Privacy Policy

USF Health Office of Continuing Professional Development (OCPD) has created a privacy policy to demonstrate our commitment to guarding the privacy of our clients. The following statements disclose our practices on gathering and disseminating information for this web site. The OCPD has security measures in place to protect the loss, misuse, and alteration of the information under our control. The OCPD does not share or sell any individual’s contact information, financial information, or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

If you have any questions about this privacy policy, please contact USF Health OCPD, at cpdsupport@health.usf.edu.

Equal Opportunity

USF is an Equal Opportunity/ Equal Access/ Affirmative Action Institution.

Contact Information

If you have technical queries about using this site, please contact: techhelp@clinicaloptions.com.

If you have credit related queries, please contact: cpdsupport@health.usf.edu.

inPractice Hepatology current certification period
Release Date: January 1, 2019
Expiration Date: June 30, 2019

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients with viral hepatitis.

Goal:

The goal of this activity is to provide a comprehensive clinical reference resource on the prevention, diagnosis, and treatment of viral hepatitis.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support

This program is supported by educational grants from AbbVie and Gilead Sciences.


inPractice HIV current certification period
Release Date: September 26, 2019
Expiration Date: September 25, 2020

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the management of patients with HIV.

Goal:

The goal of this activity is to provide a comprehensive clinical reference resource on the prevention, diagnosis, and treatment of HIV disease.

Learning Objectives:

At the conclusion of this activity, participants should be able to:

Commercial Support:

This program is supported by educational grants from Gilead Sciences and ViiV Healthcare.


For inPractice Hepatology

Physician Continuing Medical Education (for Point of Care CME activities)
USF University

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of USF Health and inPractice Resources. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF

USF Health designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 CreditTM .Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For inPractice HIV

Physician Continuing Medical Education (for Point of Care CME activities)
CCO

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CCO designates this internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Credit (Point of Care CME)

inPractice offers physicians AMA PRA Category 1 CreditTM for participation in this individual Internet point-of-care activity. Physicians may claim 0.5 credits per search. To claim point-of-care (PoC) CME credit through inPractice, eligible physicians must complete the following steps:

  1. Register online at http://www.inpractice.com
  2. Execute a search or submit a clinical question
  3. Review the applicable clinical sources
  4. Click the "Claim CME Credit" button at the top right corner of the content you have viewed
  5. Complete the simple evaluation questions addressing clinical application of learnings from the sources you have consulted

After submitting the evaluation, you will be presented with your online CME certificate as a pdf file. Records of all CME activities completed can be found on the "My CME" page.